MSI in gastric IM
| First author | IM | MSI | Microsatellite markers | ||
|---|---|---|---|---|---|
| Without coexisting GC | With coexisting GC | MSI-L (%) | MSI-H (%) | ||
| MSI-L and MSI-H are distinguished according to the criteria adopted by each author. | |||||
| GC, gastric cancer; IM, intestinal metaplasia; MSI, microsatellite instability; MSI-H/L, high/low frequency microsatellite instability. | |||||
| Garay (2004)36 | 58 | 0 | BAT26, D3S1067, D3S1262, D5S346, D12S347, D12S351 | ||
| Roa (2003)37 | 22 | 13 (59) | 0 | BAT25, BAT26, BAT40, D2S123, D3S1067, D3S1262, D3S3640, D5S346, P53CA, D17S250, C17S588, D18S55 | |
| Kim (2002)38 | 15 | 0 | BAT25, BAT26, D2S123, D5S346, D17S250, D13S170,TP53 | ||
| Jin (2001)25 | 17 | 0 | BAT25, BAT26, D2S123, D5S346, D17S250 | ||
| Leung (2000)39 | 45 | 17 (37.8) | 3 (6.7) | BAT25, BAT26, BAT40, D2S123, D5S346, D13S170, D17S250, TP53 | |
| 30 | 12 (40) | 4 (13.3) | |||
| Kobayashi (2000)40 | 33 | 11 (33) | 0 | BAT25, BAT40, D2S123, D1S103, D3S1067, D5S107, D13153, D17S261, D18S34 | |
| Hamamoto (1997)41 | 15 | 4 (26.7) | BATRII, BAT25, BAT26, BAT40, D1S191, D7S486, D11S29, TP53, D17S855 | ||
| Semba (1996)8 | 9 | 3 (33) | D2S123, D2S110, D2S136, D3S1O67, D5S5O5, D7S486, D11S29, TP53, D17S855 | ||